Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer
May 08, 2024 09:00 ET
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the Cancer Research Institute (CRI) and its Immunotherapy Platform Study...
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
May 08, 2024 09:00 ET
|
Turnstone Biologics Corp.
Dr. Sammy Farah, Turnstone's President and CEO, to present at the 2024 Bank of America Securities Health Care Conference in Las Vegas, NV.
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases
May 08, 2024 09:00 ET
|
Therini Bio, Inc.
THN391, a mAb designed to block neuroinflammation triggered by fibrin, demonstrated effectiveness in protecting against vascular and neuronal degeneration
Bloomage Demonstrates Social and Environmental Responsibility in its New Sustainability Report
May 08, 2024 09:00 ET
|
Bloomage Biotech
Parsippany, New Jersey, USA, May 08, 2024 (GLOBE NEWSWIRE) -- Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, has released its new Sustainability...
EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
May 08, 2024 08:44 ET
|
EUDA Health Holdings Ltd
Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind...
Sterilization Equipment Market is Expected to Reach $24.7 billion | MarketsandMarkets™
May 08, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 08, 2024 (GLOBE NEWSWIRE) -- Sterilization Equipment market in terms of revenue was estimated to be worth $16.8 billion in 2024 and is poised to reach $24.7 billion by 2029, growing at...
Dyadic to Attend Industry and Investor Events in May
May 08, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
MEDIA ADVISORY: INTERVIEW OPPORTUNITIES
May 08, 2024 08:00 ET
|
RTOERO
Toronto, May 08, 2024 (GLOBE NEWSWIRE) -- Interviews available with RTOERO experts, Canadian and international speakers. WHEN: Wednesday, May 15 (7–9PM)Thursday, May 16 ...
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
May 08, 2024 08:00 ET
|
Prime Medicine, Inc.
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Gran
Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
May 08, 2024 08:00 ET
|
Acumen Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic...